Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen

Purpose: Metastatic nasopharyngeal carcinoma (mNPC) remains incurable. This prospective study aimed to investigate whether adding cetuximab to cisplatin-based induction therapy could improve efficacy and survival for chemotherapy-naïve mNPC patients. Patients and Methods: Eligible chemotherapy-naïve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengping, Huang, He, Li, Xueying, Huang, Ying, Chen, Chunyan, Fang, Xiaojie, Wang, Zhao, Guo, Chengcheng, Lam, Sioteng, Fu, Xiaohong, Hong, Huangming, Tian, Ying, Lu, Taixiang, Lin, Tongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319102/
https://www.ncbi.nlm.nih.gov/pubmed/32637360
http://dx.doi.org/10.3389/fonc.2020.01011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319102/
https://www.ncbi.nlm.nih.gov/pubmed/32637360
http://dx.doi.org/10.3389/fonc.2020.01011

Ejemplares similares